Accessibility Menu
 

Guardian Pharmacy Services

(NYSE) GRDN

Current Price$35.43
Market Cap$2.18B
Since IPO (2024)+115%
5 YearN/A
1 Year+57%
1 Month+5%

Guardian Pharmacy Services Financials at a Glance

Market Cap

$2.18B

Revenue (TTM)

$1.45B

Net Income (TTM)

$49.22M

EPS (TTM)

$0.78

P/E Ratio

44.28

Dividend

$0.00

Beta (Volatility)

0.80 (Low)

Price

$35.43

Volume

21,766

Open

$34.39

Previous Close

$35.43

Daily Range

$33.59 - $35.43

52-Week Range

$19.17 - $37.43

GRDN News

GRDN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Guardian Pharmacy Services

Industry

Healthcare Providers and Services

Employees

3,600

CEO

Fred Burke

Headquarters

Atlanta, GA 30339, US

GRDN Financials

Key Financial Metrics (TTM)

Gross Margin

19%

Operating Margin

6%

Net Income Margin

3%

Return on Equity

28%

Return on Capital

35%

Return on Assets

12%

Earnings Yield

2.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.18B

Shares Outstanding

63.32M

Volume

21.77K

Short Interest

0.00%

Avg. Volume

297.27K

Financials (TTM)

Gross Profit

$282.04M

Operating Income

$88.91M

EBITDA

$111.25M

Operating Cash Flow

$100.29M

Capital Expenditure

$19.58M

Free Cash Flow

$80.71M

Cash & ST Invst.

$65.62M

Total Debt

$44.72M

Guardian Pharmacy Services Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$397.62M

+17.4%

Gross Profit

$74.83M

+11.5%

Gross Margin

18.82%

N/A

Market Cap

$2.18B

N/A

Market Cap/Employee

$640.47K

N/A

Employees

3,400

N/A

Net Income

$20.92M

+75.2%

EBITDA

$50.85M

+133.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$20.89M

+164.0%

Accounts Receivable

$101.61M

+4.6%

Inventory

$43.36M

+6.9%

Long Term Debt

$33.69M

+26.1%

Short Term Debt

$11.03M

+3.9%

Return on Assets

11.93%

N/A

Return on Invested Capital

35.29%

N/A

Free Cash Flow

$68.97M

+286.7%

Operating Cash Flow

$82.74M

+270.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TXG10x Genomics, Inc.
$18.39+0.05%
NHCNational HealthCare Corporation
$158.81+0.68%
MESOMesoblast Limited
$14.36-2.84%
TWSTTwist Bioscience Corporation
$42.07-6.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About GRDN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.